BIOXCEL THERAPEUTICS INC (BTAI) Stock Balance Sheet
NASDAQ:BTAI - Nasdaq - US09075P2048 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 31.01M | 29.85M | 65.22M | 193.70M | 233.00M | |||
| Receivables | 0.00 | 131.00K | 71.00K | 200.00K | N/A | |||
| Inventories | 642.00K | 679.00K | 1.99M | 2.00M | N/A | |||
| Other Current Assets | 6.12M | 6.73M | 4.86M | 6.90M | 3.90M | |||
| Total Current Assets | 37.78M | 37.39M | 72.14M | 202.90M | 236.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 702.00K | 857.00K | 1.47M | 2.10M | 2.50M | |||
| Other Non-Current Assets | 87.00K | 87.00K | 87.00K | 900.00K | 100.00K | |||
| Total Non-Current Assets | 789.00K | 944.00K | 1.56M | 3.00M | 2.60M | |||
| TOTAL ASSETS | 38.57M | 38.34M | 73.70M | 205.90M | 239.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.61M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 3.92M | 5.67M | 13.39M | 22.10M | 11.50M | |||
| Accounts Payable | 15.45M | 15.99M | 13.65M | 10.20M | 4.70M | |||
| Other Current Liabilities | 567.00K | 572.00K | 223.00K | 600.00K | 500.00K | |||
| Total Current Liabilities | 25.55M | 22.23M | 27.27M | 32.90M | 16.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 99.92M | 102.51M | 100.60M | 93.10M | 0.00 | |||
| Other Non-Current Liabilities | 3.27M | 6.70M | 2.35M | 3.10M | 1.10M | |||
| Total Non-Current Liabilities | 103.19M | 109.21M | 102.94M | 96.20M | 1.10M | |||
| TOTAL LIABILITIES | 128.74M | 131.44M | 130.21M | 129.10M | 17.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -657.45M | -650.20M | -590.60M | -411.50M | -245.80M | |||
| Additional Paid In Capital | 567.22M | 557.05M | 534.06M | 488.30M | 467.40M | |||
| Common Shares | 59.00K | 49.00K | 30.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 5.47M | 3.10M | 1.87M | 1.76M | 1.75M | |||
| Tangible Book Value per Share | -16.49 | -30.01 | -30.21 | 2.73 | 7.92 | |||
| Total Shareholders' Equity | -90.17M | -93.10M | -56.51M | 76.80M | 221.70M | |||
| TOTAL LIABILITIES AND EQUITY | 38.57M | 38.34M | 73.70M | 205.90M | 239.40M | |||
| Statistics | ||||||||
| Debt/Equity | -1.11 | -1.10 | -1.78 | 1.21 | N/A | |||
| Current Ratio | 1.48 | 1.68 | 2.65 | 6.17 | 14.18 | |||
| Return On Assets (ROA) | -103.88% | -155.46% | -242.94% | -80.51% | -44.67% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -215.83% | -48.23% | |||
All data in USD , ROIC based on taxRate of 0.21